AVITA Medical, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
AVITA Medical, Inc. (RCEL) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $4.75 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-12
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.75M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.04M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.76M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.40M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $4.75M 10-K · filed 2026-02-12 |
| 2024-12-31 | $3.04M 10-K · filed 2026-02-12 |
| 2023-12-31 | $3.76M 10-K · filed 2025-02-13 |
| 2022-12-31 | $3.40M 10-K · filed 2024-02-22 |
| 2021-12-31 | $2.74M 10-K · filed 2023-02-23 |
| 2021-06-30 | $3.21M 10-K · filed 2023-02-23 |
| 2020-12-31 | $2.99M 10-KT · filed 2022-02-28 |
| 2020-06-30 | $3.00M 10-KT · filed 2022-02-28 |